Tildacerfont

(Synonyms: SPR001; LY2371712)
Revisión del cliente

Based on 1 Customer Validation

Tildacerfont (SPR001; LY2371712) is an orally active, blood-brain barrier-penetrant selective corticotropin-releasing factor type 1 (CRF1) receptor antagonist. Tildacerfont selectively blocks CRF1 receptors, thereby inhibiting the release of pituitary adrenocorticotropic hormone (ACTH). Tildacerfont can be used in research related to congenital adrenal hyperplasia.

Para uso exclusivo en investigación. No vendemos a pacientes.

  • Pureza: 98.60%
  • No. CAS: 1014983-00-6
  • Fòrmula: C20H26ClN5OS
  • Peso molecular:419.97
  • Almacenamiento:

    4°C, sealed storage, away from moisture and light

    * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)

  • Actividad biológica
  • Chemical Information
  • Solvente y solubilidad
  • Pureza y Documentación
  • Referencias
  • Help & FAQs

Ver todos los productos específicos de isoformas CRFR

More
100 mg

Obtener un presupuesto En stock

Please select quantity
Amount: USD 0.00